Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Anaptysbio (ANAB) Shares Outstanding (2016 - 2025)

Anaptysbio filings provide 10 years of Shares Outstanding readings, the most recent being $28.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding fell 8.05% year-over-year to $28.0 million, compared with a TTM value of $28.0 million through Dec 2025, down 8.05%, and an annual FY2025 reading of $28.0 million, down 8.05% over the prior year.
  • Shares Outstanding hit $28.0 million in Q4 2025 for Anaptysbio, up from $27.6 million in the prior quarter.
  • The five-year high for Shares Outstanding was $30.5 million in Q4 2024, with the low at $26.5 million in Q2 2023.
  • Median Shares Outstanding over the past 5 years was $27.6 million (2021), compared with a mean of $28.0 million.
  • The sharpest move saw Shares Outstanding grew 14.57% in 2024, then fell 9.38% in 2025.
  • Year by year, Shares Outstanding stood at $27.6 million in 2021, then grew by 3.13% to $28.5 million in 2022, then fell by 6.72% to $26.6 million in 2023, then grew by 14.57% to $30.5 million in 2024, then dropped by 8.05% to $28.0 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $28.0 million, $27.6 million, and $28.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.